LB I Group Overview
- Investor Type
- PE/Buyout
- Status
- Inactive
- Investments
- 9
- Portfolio
- 1
- Exits
- 4
LB I Group General Information
Description
LB I Group was a New York, New York based private equity firm which was a direct wholly-owned subsidiary of Lehman Brothers.
Contact Information
Investor Status
Out of Business
Primary Investor Type
PE/Buyout
Primary Office
- 399 Park Avenue
- New York, NY 10023
- United States
LB I Group Investments (9)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| 0000 0000000000000 | 24-Mar-2008 | 0000 | 00000 | Pharmaceuticals | Profitable | |
| 00000000 00000000 | 16-Feb-2007 | 0000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | |
| 0000000 | 07-Nov-2006 | 0000 | 0000 | Pharmaceuticals | Generating Revenue | |
| 00000000 00000000 | 08-May-2006 | 0000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | |
| CASI Pharmaceuticals | 27-Dec-2004 | PIPE | 0000 | Biotechnology | Generating Revenue/Not Profitable |
LB I Group Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| 00000 000000000000 | 28-Feb-2018 | 000000000000000000 | 00.00 |
| 0000 0000000000000 | 23-Jan-2012 | 000000000 00000000 | 0000 |
| 0000 0000000000000 | 21-Jun-2010 | 000000000000000000 | 00.00 |
| Cytogen | 08-May-2008 | Buyout/LBO | 0000 |
LB I Group Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trial